Bubs Australia reaps benefits of US growth strategy
Bubs Australia (ASX:BUB), a maker of goat milk infant formula, organic infant food and toddler snacks, has demonstrated remarkable revenue growth on the back of a resilient US consumer.
Read More
Bubs Australia Limited
Bubs Australia aims to give accurate, useful, reliable and up-to-date information on baby nutrition of the general nature and may amend the content on this site as required. To the extent permitted by law, Bubs Australia does not accept any liability or responsibility for claims, resulting from the misinterpretation of the content of this website, which is never intended to disregard, alter or discontinue professional medical advice and/or treatment. If you are ever unsure about your baby’s development, concerned about the well-being of your bub or your own health, seek medical advice immediately without delay.
Spotlight Videos
Bubs Australia (ASX:BUB) – Webinar Presentation
Reg Weine - CEO & Managing Director - Bubs Australia (ASX:BUB) is on a mission to nourish new generations of happy bubs, with clean label nutritional products that provide the foundation for setting up a lifetime of good eating habits.
WATCH VIDEOAll Bubs Australia Limited Content
News
Bubs Australia (ASX:BUB) – Webinar Presentation
Reg Weine - CEO & Managing Director - Bubs Australia (ASX:BUB) is on a mission to nourish new generations of happy bubs, with clean label nutritional products that provide the foundation for setting up a lifetime of good eating habits.
Read More
Bubs launches infant formula clinical trial in the US
Bubs Australia (ASX:BUB), a leading infant formula and baby food company, has announced the commencement of a nationwide clinical trial in the United States.
Read More
Bubs Australia focuses on growth
06 Jul 2023 - Bubs Australia (ASX:BUB) has released the findings of its Strategic Review conducted over the past two months.
Read More
Bridge Street Bites: BUB, FLT
Tuesday's ASX session saw news from infant formula manufacturer Bubs Australia that led to a big selloff, as well as word of an acquisition by travel group Flight Centre.
Read More
Analyst Views
BUB – Citi rates the stock as Sell
Citi retains its Sell rating and lowers its target price to $0.33 from $0.35.
Read More
BUB – Citi rates the stock as Sell
Citi retains its Sell rating on Bubs Australia with a target of $0.51. The broker remains concerned about the structural pressures Australian infant formula market brands are facing.
Read More
